Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial

1996 ◽  
Vol 23 (2) ◽  
pp. 145-149 ◽  
Author(s):  
Stefan C. Grant ◽  
Lale Kostakoglu ◽  
Mark G. Kris ◽  
Samuel D. J. Yeh ◽  
Steven M. Larson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Pilot Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Gd2 Ganglioside

Detection Of N-Glycolyated Gangliosides In Non-Small Cell Lung Cancer Using The GMR8 Monoclonal Antibody

2012 ◽  
Author(s):  
Hirofumi Chiba ◽  
Nobuyoshi Hayashi ◽  
Koji Kuronuma ◽  
Mitsuo Otsuka ◽  
Masanori Shiratori ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

2007 ◽  
Vol 56 (10) ◽  
pp. 1637-1644 ◽  
Author(s):  
Martin Sebastian ◽  
Bernward Passlick ◽  
Hilke Friccius-Quecke ◽  
Michael Jäger ◽  
Horst Lindhofer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

A Pilot Trial of Gefitinib in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

2005 ◽  
Vol 6 (6) ◽  
pp. 343-349 ◽  
Author(s):  
Christian Manegold ◽  
Ulrich Gatzemeier ◽  
Erika Buchholz ◽  
Robert P. Smith ◽  
Abderrahim Fandi
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Pilot Trial ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document